Pancreatic cancer: Clinical presentation, pitfalls and early clues

Annals of Oncology

Volumn 10, Issue SUPPL. 4, 1999, Pages

  DiMagno, E P ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

CA19 9; Diabetes; IAPP (amylin); IPMT; K ras; Pancreatic cancer; Pancreatitis; Signs; Symptoms

Indexed keywords

ADENOMATOUS POLYP; ANOREXIA; CANCER RISK; CHRONIC PANCREATITIS; CLINICAL FEATURE; CONFERENCE PAPER; DIABETES MELLITUS; DYSPLASTIC NEVUS; EARLY DIAGNOSIS; FAMILIAL CANCER; HUMAN; PAIN; PANCREAS CANCER; PRIORITY JOURNAL; SATIETY; SLEEP DISORDER; WEIGHT REDUCTION;

EID: 0032784345     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/10.suppl_4.S140     Document Type: Conference Paper

References (44)

1. Riela A, Zinsmeister AR, Melton LJ et al. Increasing incidence of pancreatic cancer among women in Olmsted County, Minnesota, 1940 through 1988. Mayo Clin Proc 1992; 67: 839-645.
2. Parker SL, Tong T, Bolden S et al. Cancer statistics 1996. CA A Cancer Journal for Clinicians 1996; 46: 5-27.
3. Niederhuber JE, Brennan MF, Menck HR. The National Cancer Data Base report on pancreatic cancer. Cancer 1995; 76: 1671-7.
4. Nitecki SS, Sar MG, Colby TV et al. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg 1995; 221: 59-66.
5. DiMagno EP, Malagelada J-R, Taylor WP et al. A prospective comparison of current diagnostic tests in pancreatic cancer. N Engl J Med 1977; 97: 737-42.
6. Krech RL, Walsh D. Symptoms of pancreatic cancer. J Pain Symptom Management 1991; 6: 360-7.
7. Ridder GJ, Klempnauer J. Back pain in patients with ductal pancreatic cancer. Its impact on resectabilit and prognosis after resection. Scand J Gastroenterol 1995; 30: 1216-1220.
8. Tarpila E, Borch K, Kullman E et al. Pancreatic cancer. Ann Chir Gynaecol 1986; 75:146-50.
9. Svendsen JH, Munck LK, Andersen JR. Irritable bowel syndrome - prognosis and diagnostic safety. A 5-year follow-up study. Scand J Gastroenterol 1985; 20: 415-8.
10. Grahm AL, Andren-Sandberg A. Prospective evaluation of pain in exocrine pancreatic cancer. Digestion 1997; 58:542-9.
11. Lowenfels AB, Maisonneuve P, DiMagno EP et al. International Hereditary Pancreatitis Study Group: Hereditary pancreatitis and the risk of pancreatic cancer. J Natl Cancer Inst 1997;89:442-6.
12. Whitcomb DC, Gorry MC, Preston RA et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nature Genetics 1996; 14: 141-5.
13. Gorry MC, Gabbaizedeh D, Furey W et al. Mutations in the cationic trypsinogen gene are associated with recurrent acute and chronic pancreatitis. Gastroenterology 1997; 113: 1063-8.
14. Lowenfels AB, Maisonneuve P, Cavallini G et al. International Pancreatitis Study Group. Pancreatitis and the risk of pancreatic cancer. New Engl J Med 1993; 328: 1433-7.
15. Bansal P, Sonnenberg A. Pancreatitis is a risk factor for pancreatic cancer. Gastroenterology 1995; 109: 247-51.
16. Karlson BM, Ekbom A, Josefsson S et al. The risk of pancreatic cancer following pancreatitis: an association due to confounding? Gastroenterology 1997; 113: 587-92.
17. Ohashi K, Takagi K. ERCP and imaging diagnosis of pancreatic cancer. Gastrointestinal Endosc 1997; 77:1493-5 (in Japanese with English abstract).
18. Loftus EV Jr, Olivares-Pakzad BA, Batts KP et al. Intraductal papillary-mucinous tumors of the pancreas-clinicopathologic features, outcome, and nomenclature. Gastroenterology 1996; 110: 1909-18.
19. Rivera JA, Fernandez-del Castillo C, Pins M et al.. Pancreatic mucinous ductal ectasia and intraductal papillary neoplasms. A single malignant clinicopathologic entity. Ann Surg 1997; 225: 637-44.
20. McDowell RK, Gazelle GS, Murphy BL et al. Mucinous ductal ectasia of the pancreas. J Computer Assisted Tomography 1997; 21: 383-8.
21. Sessa F, Solcia E, Capella C et al. Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients. Virchows Arch 1994; 425: 357-67.
22. Gullo L, Pezzilli R, Morselli-Labate AM, Italian Pancreatic Cancer Study Group. Diabetes and the risk of pancreatic cancer. New Engl J Med 1994; 331 :81-4.
23. Permert J, Larsson J, Westermark GT et al. Islet amyloid polypeptide in patients with pancreatic cancer and diabetes. New Engl J Med 1994; 330: 313-8.
24. Schwarts SS, Zeidler A, Moossa AR et al. A prospective study of glucose intolerance, insulin, C-peptide, and glucagon in patients with pancreatic carcinoma. Am J Dig Dis 1978; 23: 1107-14.
25. Everhart J and Wright D. Diabetes mellitus as a risk factor for pancreatic cancer. J Am Med Assoc 1995; 273: 1605-9.
26. Ghadirian P, Boyle P, Simard A et al. Reported family aggregation of pancreatic cancer within a population-based case-control study in the Francophone community in Montreal, Canada. Internatl J Pancreatol 1991; 10: 183-96.
27. Lynch HT, Fitzsimmons ML, Smyrk TC et al. Familial pancreatic cancer: clinicopathologic study of 18 nuclear families. Am J Gastroenterol 1990; 85: 54-60.
28. Norton ID, Petersen BT, Miller LJ et al. Frequency of a family history of pancreatic malignancy in patients with pancreatic malignancy. Pancreas 1998; 17: 451.
29. Giardiello FM, Offerhaus GJ, Lee DH et al. Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. Gut 1993; 34: 1394-6.
30. Lynch HT, Fusaro RM. Pancreatic cancer and the familial atypical multiple mole melanoma. Pancreas 1991; 6: 127-31.
31. Goldstein AM, Fraser MC, Struewing JP et al. Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations. N Engl J Med 1995; 333: 970-4.
32. Patrianakos C, Hoffman D. Chemical studies on tobacco smoke LXIV. On the analysis of aromatic amines in cigarette smoke. J Anal Toxicol 1979; 3: 150-9.
33. Norell SE, Ahlbom A, Erwald R et al. Diet and pancreatic cancer: a case-control study. Am J Epidemiol 1986; 124: 894-902.
34. Sugimura T. Carcinogenicity of mutagenic heterocyclic amines formed during the cooking process. Mutat Res 1985; 150: 33-41.
35. Sugimura T, Sato S. Mutagens-carcinogens in foods. Cancer Res 1983; 43: 2415s-21s.
36. Mack TM, Yu MC, Hanisch R et al. Pancreas cancer and smoking, beverage consumption and past medical history. J Natl Cancer Inst 1986; 76: 49-60.
37. Falk RT, Pickle LW, Fontham ET et al. Life-style risk factors for pancreatic cancer in Louisiana: a case-control study. Am J Epidemiol 1988; 128: 324-36.
38. Mills PK, Beeson L, Abbey DE et al. Dietary habits and past medical history as related to fatal pancreas cancer risk among Adventists. Cancer 1988; 61: 2578-85.
39. Mack TM. Pancreas. IN: Schottenenfeld D, Fraumeni JF Jr (eds). Cancer epidemiology and prevention. WB Saunders Co, Philadelphia, 1982.
40. Falk RT, Pickle LW, Fontham ET et al. Occupation and pancreatic cancer risk in Louisiana. Am J Int Med 1990; 18: 565-76.
41. Steinmetz KA, Potter JD. Vegetables, fruit, and cancer. I. Epidemiology. Cancer Causes and Control 1991; 2: 325-7.
42. Steinmetz KA, Potter JD. Vegetables, fruit, and cancer. II. Mechanisms. Cancer Causes and Control 1991; 2: 427-42.
43. Chari ST, Miller LJ, DiMagno EP. Elderly, overweight subjects with recent onset diabetes-a high risk group for pancreatic cancer (PC)? Gastroenterology, in press.
44. Chari S, Klee GG, Miller LJ et al. Sensitivity and specificity of CA19-9 and islet amyloid polypeptide (IAPP) for symptomatic pancreatic cancer (PC). Pancreas 1998; 17: 429.